KLF16 and nonpapillary renal cell carcinoma: Collectively, these data provide a novel insight into the functional roles of SF3B4-KLF16-Twist1 axis in the development and progression of ccRCC, and manipulating this pathway may be a novel therapeutic target for the treatment of ccRCC (Fig. 9).